Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |